Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R.1625 Consolidated Appropriations Act, 2018 H.R.2212 / S.974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
H.R.1625 Consolidated Appropriations Act, 2018 H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.908 Issues related to Medicare Advantage and the benchmark cap.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COREWELL HEALTH via COREWELL HEALTH
2018 · third_quarter · Q3
HR908 Issues related to Medicare Advantage and the benchmark cap.
HR3325 & S.428: ACE Kids Act HR908: Issues related to Medicare Advantage benefits and the benchmark cap. Discussions regarding ACA Risk-Adjustment program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
H.R.1625 Consolidated Appropriations Act, 2018 H.R.2212 / S.974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
HR3325 & S.428: ACE Kids Act HR908: Issues related to Medicare Advantage benefits and the benchmark cap. Discussions regarding ACA Risk-Adjustment program
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.1625 Consolidated Appropriations Act, 2018 H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.908 Issues related to Medicare Advantage and the benchmark cap.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program
Medicare Advantage Quality Payment Relief Act of 2017
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.908 Issues related to Medicare Advantage and the benchmark cap.
Medicare Advantage Quality Payment Relief Act of 2017
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
HR908 Issues related to Medicare Advantage and the benchmark cap.
Medicare Advantage Quality Payment Relief Act of 2017
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.1625 Consolidated Appropriations Act, 2018 H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.908 Issues related to Medicare Advantage and the benchmark cap.
Medicare Advantage Quality Payment Relief Act of 2017
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
HR3325 & S.428: ACE Kids Act HR908: Issues related to Medicare Advantage benefits and the benchmark cap. Discussions regarding ACA Risk-Adjustment program
HR3325 & S.428: ACE Kids Act HR908: Issues related to Medicare Advantage benefits and the benchmark cap. Discussions regarding ACA Risk-Adjustment program
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.1625 Consolidated Appropriations Act, 2018 H.R.2212 / S.974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
H.R.1628 - Better Care Reconciliation Act of 2017; Discussions regarding potential new health law.
Discussions about changes to the Patient Protection and Affordable Care Act (PPACA). H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. Discussions regarding extension of Affordable Care Act Transitional Policy Through December 31, 2018.
Discussions about changes to the Patient Protection and Affordable Care Act (PPACA). H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. Discussions regarding extension of Affordable Care Act Transitional Policy Through December 31, 2018.
H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. H.R.1628 - Better Care Reconciliation Act of 2017; Discussions regarding potential new health law.
S. 1827 - KIDS Act; Discussions regarding CHIP reauthorization H. R. 2212 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: COREWELL HEALTH · Firm: COREWELL HEALTH
H.R.4392 - Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.4710 - 340B PAUSE Act: Discussions regarding potential law regarding the 340B program. S. 1827 - KIDS Act; Discussions regarding reauthorization of the Childrens Health Insurance Program (CHIP). Supported various efforts to reauthorize Medicare Extenders.
H.R.4392 - Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.4710 - 340B PAUSE Act: Discussions regarding potential law regarding the 340B program. S. 1827 - KIDS Act; Discussions regarding reauthorization of the Childrens Health Insurance Program (CHIP). Supported various efforts to reauthorize Medicare Extenders.
H.R.4392 - Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.4710 - 340B PAUSE Act: Discussions regarding potential law regarding the 340B program. S. 1827 - KIDS Act; Discussions regarding reauthorization of the Childrens Health Insurance Program (CHIP). Supported various efforts to reauthorize Medicare Extenders.
S. 1827 - KIDS Act; Discussions regarding CHIP reauthorization H. R. 2212 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
2018 · second_quarter · Q2
H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program
H.R.908 Issues related to Medicare Advantage and the benchmark cap.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COREWELL HEALTH via COREWELL HEALTH
2018 · first_quarter · Q1
H.R.1625 Consolidated Appropriations Act, 2018 H.R.4392 Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.908 Issues related to Medicare Advantage and the benchmark cap.
H.R.1625 Consolidated Appropriations Act, 2018 H.R.2212 / S.974 Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COREWELL HEALTH via COREWELL HEALTH
2017 · fourth_quarter · Q4
H.R.4392 - Discussions regarding bill to reverse CMS final rule reducing payments for the 340B program. H.R.4710 - 340B PAUSE Act: Discussions regarding potential law regarding the 340B program. S. 1827 - KIDS Act; Discussions regarding reauthorization of the Childrens Health Insurance Program (CHIP). Supported various efforts to reauthorize Medicare Extenders.
S. 1827 - KIDS Act; Discussions regarding CHIP reauthorization H. R. 2212 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017: Discussions regarding proposed law to expedite generics to market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COREWELL HEALTH via COREWELL HEALTH
2017 · third_quarter · Q3
H.R.1628 - Better Care Reconciliation Act of 2017; Discussions regarding potential new health law.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COREWELL HEALTH via COREWELL HEALTH
2017 · second_quarter · Q2
H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. H.R.1628 - Better Care Reconciliation Act of 2017; Discussions regarding potential new health law.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COREWELL HEALTH via COREWELL HEALTH
2017 · first_quarter · Q1
Discussions about changes to the Patient Protection and Affordable Care Act (PPACA). H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. Discussions regarding extension of Affordable Care Act Transitional Policy Through December 31, 2018.
Discussions about changes to the Patient Protection and Affordable Care Act (PPACA). H.R.1628 - American Health Care Act of 2017; Discussions regarding potential new health law. Discussions regarding extension of Affordable Care Act Transitional Policy Through December 31, 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE